CYP enzymes - ◦ enzyme induction - liver produces extra enzyme to break down drug with continued...

68
CYP enzymes - enzyme induction - liver produces extra enzyme to break down drug with continued exposure Genetics

Transcript of CYP enzymes - ◦ enzyme induction - liver produces extra enzyme to break down drug with continued...

Page 1: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

CYP enzymes -◦ enzyme induction -

liver produces extra enzyme to break down drug with continued exposure

Genetics

Page 2: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 3: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Pharmacokinetics

Page 4: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 5: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 6: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 7: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Estimates that there is a 10-year gap between medically relevant bio-technological advances and appropriate application, or translation into routine medical practice

Page 8: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Enzyme Inhibition◦ Some drugs inhibit CYP enzymes and

increase their own levels, as well as levels of any other drug metabolized by that enzyme. Can produce toxicities.

◦ Example: Inhibition of antipsychotic medication by SSRIs.

Pharmacokinetics

Page 9: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

CYP enzymes -◦enzyme induction - liver produces extra enzyme to break

down drug with continued exposureGenetics

Liver disease

Page 10: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

cirrhotic liver

Page 11: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

In some cases, biotransformation can be to another psychoactive compound

ex. benzodiazepenes

diazepam nordiazepam oxazepam

Page 12: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Excretion ◦ Primarily accomplished by kidneys.

2 organs (about the size of a fist) located on either side of the spine in the back.

Keep the right balance of water and salt in the body

Filter everything out of blood and then selectively reabsorb what is required.

Can be useful for eliminating certain drugs in overdose.

Pharmacokinetics

Page 13: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

all drugs not in gaseous state need to use fluid routes of excretion◦ fluid routes include -sweat, tears, saliva, mucous,

urine, bile, human milk

◦ amount of drug excreted in each of these fluids is in direct proportion to amount of fluid excreted SO…….

Page 14: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Sometimes drugs are not metabolized and are excreted intact.◦ Lithium ◦ Mushroom amanita muscaria

In large doses it is toxic and lethal; small amounts are hallucinogenic.

Hallucinogenic ingredients are not greatly metabolized and are passed to the urine. Siberian tribespeople discovered this and recycled the drug by drinking their urine.

Pharmacokinetics

Page 15: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Sometimes drugs are not metabolized and are excreted intact.◦ Lithium ◦ Mushroom amanita muscaria

In large doses it is toxic and lethal; small amounts are hallucinogenic.

Hallucinogenic ingredients are not greatly metabolized and are passed to the urine. Siberian tribespeople discovered this and recycled the drug by drinking their urine.

Pharmacokinetics

Page 16: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

absorption, distribution and excretion do not occur independently

Page 17: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

1. Body weight - smaller size • concentration of drug based on body fluid

2. Sex differences

3. Age

Page 18: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

4. Interspecies differences rabbits – belladonna (deadly nightshade)

5. Intraspieces differences

6. Disease states

7. Nutrition

8. Biorhythm - chronopharmacology

Page 19: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

half-life - time takes for the blood concentration to fall to half its initial value after a single dose

½ life tells us critical information about how long the action of a drug will last

Page 20: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 21: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Table 1.4Julien: A Primer of Drug Action, Eleventh EditionCopyright © 2008 by Worth Publishers

Page 22: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

How long would it take for a drug to reach 12.5% remaining in blood if its ½ life is 2 hours?

How long would it take for a drug to reach 12.5% remaining in blood if its ½ life is 100 hours?

Page 23: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Provides a good indication of the time necessary to reach steady state after a dosage regime has been initiated (6X)

Page 24: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

drug elimination = drug availability

usually try and maintain steady state concentration in therapeutic window

Page 25: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 26: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

So if a drug had a 3 hour ½ life – how long would it take to reach steady state?

Page 27: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Therapeutic drug monitoring - branch of clinical chemistry that specializes in the measurement of medication levels in blood. Its main focus is on drugs with a narrow therapeutic range,

Page 28: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

- need to reach threshold plasma concentration at the receptor site to initiate and maintain a pharmacological response. ◦ assume that plasma represents good indicator of

local site

TDM is actually indirect

How is TDM determined?

Page 29: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

What happens if?

◦ Plasma levels are too high –

◦ Plasma levels are too low –

Focus on levels rather than dose

Page 30: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Determine if patient is taking drug as prescribed

Avoid toxicity Enhance therapeutic process Reduction in cost of therapy

Page 31: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Definition:

Types of tolerance:◦ Metabolic tolerance:

Type of pharmacological tolerance◦ Pharmacological Tolerance◦ Behavioral conditioning

Physical dependence:◦ Entirely different than tolerance

Page 32: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Pharmacodynamics◦ drugs produce their effects by binding to and

interacting with receptors

What is a receptor?◦ usually a protein on the surface or in the cell

Page 33: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 34: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

each NT binds to its own receptors◦ there can be multiple receptor subtypes

Page 35: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 36: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

each NT binds to its own receptors◦ there can be multiple receptor subtypes

useful for understanding drugs that work on the specific neurotransmitters

Page 37: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 38: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Given drug may be more specific for a given set of receptors than is the endogenous nt◦ 5HT – (serotonin) – attaches to more than 15 nt

receptors – ◦ Buspirone (BuSpar) attaches to 5HT 1A but no

affinity for other 5HT receptors.

Page 39: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Bind to the receptor site that nt normally binds to; acts just like nt◦ Agonist

Can facilitate endogenous nt; ◦ Agonist◦ Allosteric action

Bind to the receptor site but do not initiate transmitter-like activity◦ Antagonistic effect

Page 40: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Drugs exert effects by forming reversible bonds w specific receptor

100s of different types of receptors w ability to recognize 1 nt characterizes each of these

Drugs do not create any unique effects – modulate normal neuronal functioning

Page 41: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Several configurations of proteins Ion channel receptors

◦ ionotropic

Page 42: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

1. ionotropic postsynaptic receptors quick action and over quickly

◦ “ion channel receptors”

Page 43: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 44: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Ion channel - close

Copyright © motifolio.com

7111232

Page 45: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Ion channel - open

Copyright © motifolio.com

7111231

Page 46: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Copyright © motifolio.com

Ligand-gated channels

Neurotransmitterreceptor

Ca2+ -activatedK+ channel

Cyclic nucleotidegated channel

Na+

K+

Glu

K+

Ca2+

Na+

K+

cAMP

cAMP

cGMP

7111158

Page 47: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 48: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

2. G-protein coupled receptors ◦ (metabotropic)◦ 2nd messenger systems◦ more than 50 G protein coupled receptors have

been identified (large and diverse family)◦ control many cellular processes◦ Involved in synaptic effects of many nt

Page 49: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 50: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

3. carrier proteins (transporter)

◦ presynaptic transporters – transport NT back into presyn ending

4. enzymes –◦ what is an enzyme?◦ breakdown NT -

Page 51: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

receptors exhibit high specificity for specific nt (and certain drugs)

Minor modification in structure of drug can have major impact

Page 52: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

info on a range of doses of drug

dose usually presented on horizontal axis (log concentration)

size of effect or percentage affected usually on vertical axis

Page 53: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 54: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

the intensity or magnitude of the response in a single person

the % of people who exhibit a characteristic effect at a given dosage

Page 55: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 56: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

potency - amount of drug required to elicit a response

slope of the line tells you about how much difference in drug is needed for small effects relative to larger effect

Page 57: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 58: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Efficacy - maximum effect obtainable - peak of the DRC indicates the maximum effect

Page 59: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 60: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 61: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 62: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Variability and slope –individual differences in drug response

Page 63: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.
Page 64: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

A. As dose increases; effect increasesB and C - maximal effect that dose can reach (differ in efficacy)D. Inverted U function - works better at intermediate doses than higher or lower doses

Page 65: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Different DRC depending upon measure of interest

Page 66: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

ED 50 - The dose of a drug that produces the desired effect in 50% of the population

LD 50 –

TI = Therapeutic Index – measure of safety LD 50/ED 50

Page 67: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

hypothetical drug that can be used as a sedative – this is tested in mice –

** dose cannot guarantee 100% sleeping and no deaths

Page 68: CYP enzymes - ◦ enzyme induction -  liver produces extra enzyme to break down drug with continued exposure  Genetics.

Caution in interpreting DRCOften see a bell-shaped curve in response to drug